4-OI promotes VSV?51 infection and oncolysis. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-48422-x When a cancer cell doesn’t respond to traditional therapies, doctors may turn to a sort of viral biological warfare, by deploying “troops” in the form of viral agents that are specifically engineered to target and eliminate cancer cells. The mode of attack is to transform the tumor into an immunologically “hot” environment, making it more visible and recognizable to our immune system. Now, researchers from the Department of Biomedicine at Aarhus University have found a way to make Read More